Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Tariq Munshi

Tariq Munshi

Queen's University, Canada

Title: Metabolic syndrome: A psychiatric perspective

Biography

Biography: Tariq Munshi

Abstract

Statement: Metabolic syndrome is a term that describes a group of conditions that puts an individual at risk for cardiovascular disease. This term represents increased waist circumference which is regarded as a central feature, lipid dysregulation, raised  fasting blood glucose and presence of hypertension. It has been known over the years as insulin resistance syndrome, syndrome X, the deadly Quartet since the 1920’s. The criteria used mostly is International Diabetes Federation and the United States National Cholesterol Educational Program Adult Treatment Panel (NCEPATP) III criteria for metabolic syndrome.
Orientation: People with severe mental illness such as schizophrenia and bipolar disorder are at increased risk of developing cardiovascular disease, as a result of multiple aetiology including genetic, life style, disease specific as well as effect of treatment. They live 25 years less than general population and complications arising from cardiovascular disease are among the leading cause of death for people with chronic schizophrenia.
Significance: The high risk patients need to be identified at the outset so an individualised care plan can be formulated. Education regarding life style changes, prescribing suitable psychotropic medication, establishing a temporal relationship and identifying the variables to make a management plan is vital.
Learning Objectives: At the end of this session participants will be able to: 1. Be aware of the prevalence of metabolic syndrome in psychiatric population. 2. Highlight the importance of identifying the risk factors for developing metabolic syndrome in psychiatric inpatient setting at an early stage.